Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to ...
Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to ...
Trial in progress: Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma. Phase I study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTE immune ...
Neoadjuvant and adjuvant capmatinib in resectable non–small cell lung cancer with MET exon 14 skipping mutation or high MET amplification: GEOMETRY-N trial. This is an ASCO Meeting Abstract from the ...
NEW YORK, (February 12, 2026) – A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy ...
(Singapore, September 11, 2023, 10:05 a.m. SGT) – Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results